Evidence map›Paper›PMID 33738517›Full record

ArticleEuropean journal of pediatrics2021

Drug compatibility in neonatal intensive care units: gaps in knowledge and discordances.

Alba Fernández-Peña, Alberto Katsumiti, Amaya De Basagoiti, Mikel Castaño, Goizane Ros, Saioa Sautua, Monike De Miguel, Ainara Campino

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of pediatrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alba Fernández-PeñaOsakidetza Basque Health Service, Cruces University Hospital, Department of Hospital Pharmacy, Barakaldo, Spain.ORCID https://orcid.org/0000-0003-1502-354X
Alberto KatsumitiBiocruces Bizkaia Health Research Institute, Barakaldo, Spain.ORCID https://orcid.org/0000-0003-4145-4853
Amaya De BasagoitiOsakidetza Basque Health Service, Cruces University Hospital, Department of Hospital Pharmacy, Barakaldo, Spain.ORCID https://orcid.org/0000-0003-0894-9539
Mikel CastañoOsakidetza Basque Health Service, Cruces University Hospital, Department of Hospital Pharmacy, Barakaldo, Spain.
Goizane RosOsakidetza Basque Health Service, Cruces University Hospital, Department of Hospital Pharmacy, Barakaldo, Spain.
Saioa SautuaOsakidetza Basque Health Service, Cruces University Hospital, Department of Hospital Pharmacy, Barakaldo, Spain.
Monike De MiguelOsakidetza Basque Health Service, Cruces University Hospital, Department of Hospital Pharmacy, Barakaldo, Spain.
Ainara CampinoOsakidetza Basque Health Service, Cruces University Hospital, Department of Hospital Pharmacy, Barakaldo, Spain. ainara.campinovillegas@osakidetza.eus.ORCID http://orcid.org/0000-0001-7974-5408

Funding

Department of Health of the Basque Government: Physical stability study of alprostadil with Y- site administrated drugs in neonatal intensive care units, 2018-2020 2018111014
6 · The paper itself

Abstract

In this work, we reviewed the compatibility data of drug combinations frequently administrated in nine Spanish neonatal intensive care units (NICUs) and analyzed the degree of agreement among three highly used databases (Micromedex, King Guide to Parenteral Admixtures, and Stabilis) through Cohen's kappa coefficient statistical analysis. Among 1945 drug combinations analyzed, 283 were compatible, 421 were potentially compatible, 216 were incompatible, 139 were controversial, and there was no data for 886 combinations. In general, the three databases showed a strong degree of agreement: Micromedex vs. King Guide (κ = 0.746; p < 0.001), King Guide vs. Stabilis (κ = 0.743; p < 0.001), and Micromedex vs. Stabilis (κ = 0.691; p < 0.001). However, in 6 of 648 (Micromedex vs. King Guide), 3 of 357 (King Guide vs. Stabilis), and 32 of 606 (Micromedex vs. Stabilis) comparisons, drug pairs were compatible according to the first database and incompatible according to the second, indicating discordances among databases.Conclusion: There is a gap in knowledge about physical compatibility of a great number of drug combinations commonly used in NICUs. Although the three databases showed strong concordance, for some drug combinations, important discrepancies were found. Thus, there is a need for further studies on drug compatibility to increase safety of intravenous administration. What is Known: • Y site-administration in NICUs is very common and some administration errors are related to the lack of information on the compatibility of intravenous drugs. • Physical compatibility data of drugs frequently used in NICUs is still very limited. What is New: • Physical compatibility data of drug combinations commonly used in Spanish NICUs was reviewed in three highly used admixture databases: Micromedex, King Guide to Parenteral Admixtures and Stabilis, and our results showed a strong degree of agreement between them, however for some drug combinations, important discrepancies were found. • Our results indicated that there is still a large gap in knowledge about physical compatibility of a great number of drug combinations commonly used in NICUs..

Indexed as

Pharmaceutical PreparationsAdministration, IntravenousHumansInfant, NewbornInfusions, IntravenousIntensive Care Units, NeonatalParenteral NutritionPharmaceutical PreparationsDrug administrationDrug admixturesNeonatal intensive care unitsPharmaceutical databases

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.